Effects of COVID-19 on Arrhythmia
Open Access
- 2 September 2022
- journal article
- review article
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (9) , 292
Abstract
The World Health Organization announced that COVID-19, with SARS-CoV-2 as its pathogen, had become a pandemic on 11 March 2020. Today, the global epidemic situation is still serious. With the development of research, cardiovascular injury in patients with COVID-19, such as arrhythmia, myocardial injury, and heart failure, is the second major symptom in addition to respiratory symptoms, and cardiovascular injury is related to the prognosis and mortality of patients. The incidence of arrhythmia in COVID-19 patients ranges from 10% to 20%. The potential mechanisms include viral infection-induced angiotensin-converting enzyme 2 expression change, myocarditis, cytokine storm, cardiac injury, electrophysiological effects, hypoxemia, myocardial strain, electrolyte abnormalities, intravascular volume imbalance, drug toxicities and interactions, and stress response caused by virus infection. COVID-19 complicated with arrhythmia needs to be accounted for and integrated in management. This article reviews the incidence, potential mechanisms, and related management measures of arrhythmia in COVID-19 patients.Keywords
Funding Information
- National Natural Science Foundation of China (82172060)
- Department of Science and Technology of Sichuan Province (2022YFS0362, 2022YFS0363)
This publication has 148 references indexed in Scilit:
- Febrile temperature facilitates hERG/IKr degradation through an altered K+ dependenceHeart Rhythm, 2016
- Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritisEuropean Heart Journal, 2016
- Macrolide antibiotics and the risk of ventricular arrhythmia in older adultsCanadian Medical Association Journal, 2016
- Long QT Syndrome: An Emerging Role for Inflammation and ImmunityFrontiers in Cardiovascular Medicine, 2015
- Antiarrhythmic Potential of Anticytokine Therapy in Rheumatoid Arthritis: Tocilizumab Reduces Corrected QT Interval by Controlling Systemic InflammationArthritis Care & Research, 2014
- Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: Incidence and risk factorsAmerican Heart Journal, 2013
- Role of acute infection in triggering acute coronary syndromesThe Lancet Infectious Diseases, 2010
- Blockade of HERG channels by HIV protease inhibitorsThe Lancet, 2005
- Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cellsEuropean Journal of Pharmacology, 2004
- Role of electrolytes in etiology and management of cardiac arrhythmiasProgress in Cardiovascular Diseases, 1966